Literature DB >> 25246598

On the use of 2,5-dimethyl-pyrrol-1-yl-benzoic acid derivatives as EPH-ephrin antagonists.

Alessio Lodola1, Matteo Incerti2, Massimiliano Tognolini1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25246598      PMCID： PMC4178705          DOI： 10.1128/JVI.02152-14

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  7 in total

1.  The platelet P2Y12 receptor contributes to granule secretion through Ephrin A4 receptor.

Authors:  Erik Tournoij; C Arnold Koekman; Vivian X Du; Mark Roest; Rob Ruijtenbeek; Frans L Moll; Jan-Willem N Akkerman
Journal:  Platelets       Date:  2012-01-24       Impact factor: 3.862

2.  Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.

Authors:  Roberta Noberini; Mitchell Koolpe; Satyamaheshwar Peddibhotla; Russell Dahl; Ying Su; Nicholas D P Cosford; Gregory P Roth; Elena B Pasquale
Journal:  J Biol Chem       Date:  2008-08-26       Impact factor: 5.157

3.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

Authors:  Jonathan B Baell; Georgina A Holloway
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

4.  A detective story in drug discovery: elucidation of a screening artifact reveals polymeric carboxylic acids as potent inhibitors of RNA polymerase.

Authors:  Weixing Zhu; Matthias Groh; Jörg Haupenthal; Rolf W Hartmann
Journal:  Chemistry       Date:  2013-05-16       Impact factor: 5.236

5.  A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptors.

Authors:  Roberta Noberini; Surya K De; Ziming Zhang; Bainan Wu; Dhanya Raveendra-Panickar; Vida Chen; Jesus Vazquez; Haina Qin; Jianxing Song; Nicholas D P Cosford; Maurizio Pellecchia; Elena B Pasquale
Journal:  Chem Biol Drug Des       Date:  2011-09-06       Impact factor: 2.817

6.  EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans.

Authors:  Annelies Van Hoecke; Lies Schoonaert; Robin Lemmens; Mieke Timmers; Kim A Staats; Angela S Laird; Elke Peeters; Thomas Philips; An Goris; Bénédicte Dubois; Peter M Andersen; Ammar Al-Chalabi; Vincent Thijs; Ann M Turnley; Paul W van Vught; Jan H Veldink; Orla Hardiman; Ludo Van Den Bosch; Paloma Gonzalez-Perez; Philip Van Damme; Robert H Brown; Leonard H van den Berg; Wim Robberecht
Journal:  Nat Med       Date:  2012-09       Impact factor: 53.440

7.  Binding of the Kaposi's sarcoma-associated herpesvirus to the ephrin binding surface of the EphA2 receptor and its inhibition by a small molecule.

Authors:  Alexander S Hahn; Ronald C Desrosiers
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103
  7 in total
  2 in total

1.  Reply to "On the use of 2,5-dimethyl-pyrrol-1-yl-benzoic acid derivatives as EPH-ephrin antagonists".

Authors:  Ronald C Desrosiers; Alexander S Hahn
Journal:  J Virol       Date:  2014-10       Impact factor: 5.103

Review 2.  Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile Acids.

Authors:  Lorenzo Guidetti; Riccardo Castelli; Laura Scalvini; Francesca Ferlenghi; Miriam Corrado; Carmine Giorgio; Massimiliano Tognolini; Alessio Lodola
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.